Senators press Moderna CEO on COVID-19 vaccine price hike Moderna’s CEO is defending a plan to more than quadruple the company’s COVID-19 vaccine price The Independent UK · Mar 22, 2023
Novartis scraps cholesterol drug trial in blow to UK life sciences ambitions Swiss firm’s withdrawal from Leqvio trial with NHS dents government plans to attract post-Brexit research and investment The Guardian - UK · Mar 22, 2023
LOCALIZE IT: States weigh stricter fentanyl penalties EDITORS/NEWS DIRECTORS: The Independent UK · Mar 20, 2023
The Best Medical Stock That Money Can Buy The medical industry, which thrived during the pandemic years, is envisioned to remain buoyed despite the economic headwinds, thanks to the inelastic demand the sector faces. Against this backdrop, we think the strong fundamentals of Johnson and Johnson (JNJ) make it a wise portfolio addition. Read on…. StockNews.com · Mar 20, 2023
US issues warning about Mexican pharmacies selling tainted, counterfeit pills The U.S. State Department issued a warning Friday for Americans to “exercise caution” when buying medications from drug stores in Mexico, posting the health alert a week after a letter from two lawmakers and an investigation by the Los Angeles Times. Los Angeles Times · Mar 19, 2023
Newsom announces $50 million contract to make California’s own brand of insulin LOS ANGELES — California Gov. Gavin Newsom announced a new $50-million contract with the nonprofit generic drugmaker Civica to produce insulin under the state’s own label during a news conference Saturday in Downey. Los Angeles Times · Mar 18, 2023
Four people forced to have their eyeballs removed after using contaminated eye drops The Centres for Disease Control and Prevention has identified a rare strain of Pseudomonas aeruginosa in 68 patients across 16 states in the US due to contaminated eyedrops Daily Mirror · Mar 17, 2023
Amid U.S. pressure on fentanyl, Mexico raises drug lab raids data Mexico's army has dramatically revised upward the number of drug lab raids it says it conducted under President Andres Manuel Lopez Obrador, according to government data and leaked military documents reviewed by Reuters. Reuters · Mar 17, 2023
Firm behind Wegovy slimming jab suspended from UK trade association Novo Nordisk found to be in breach of ABPI code of practice over sponsored weight-loss courses that promoted its medicines The Guardian - UK · Mar 16, 2023
Judge weighs FDA approval of abortion drug WASHINGTON — A federal district judge heard oral arguments Wednesday in a controversial case that could decide the fate of the Food and Drug Administration’s approval of the abortion drug mifepristone — a decision that would have broad ramifications nationwide. Tribune News Service · Mar 15, 2023
Federal government to penalize AbbVie over the price of its blockbuster drug Humira North Chicago-based drugmaker AbbVie must pay back Medicare for raising the price of its blockbuster drug Humira too quickly, the federal government said Wednesday. Chicago Tribune · Mar 15, 2023
Jeremy Hunt aims to spur business investment with ‘full expensing’ tax break Measure over next three years will allow firms to write off costs of IT equipment and machinery against tax on profits The Guardian - UK · Mar 15, 2023
Governments are increasingly reliant on consulting firms. Critics says it's often to their detriment Critics say governments are outsourcing their own knowledge and activities to consulting firms, yet these firms aren't held to the same standards as the public sector. ABC News · Mar 15, 2023
‘Near-automatic sign off’ – Hunt pledges £10m to speed up access to new drugs The Chancellor said that £10 million would be awarded to help streamline approvals for new medical products. The Independent UK · Mar 15, 2023
StockNews.com · Mar 15, 2023 The Smartest Stock to Buy for Under $50 Now Pharma giant Pfizer (PFE) had a successful fiscal year 2022 with record-breaking revenue and earnings. Moreover, its recent acquisition should boost its portfolio and revenue. Given the market volatility, this fundamentally strong stock might be an ideal buy for under $50. Keep reading.
StockNews.com · Mar 14, 2023 1 Stock to Buy This Week and Hold for the Next 20 Years Although the stock market remains highly volatile, investing for the long term can never be timed perfectly. I believe buying fundamentally strong biopharmaceutical major Bristol-Myers Squibb (BMY) now for the long term could be wise, given the solid prospects of its new drug launches. Read more….
The Independent UK · Mar 14, 2023 Novo Nordisk to slash insulin price by up to 75% in push for affordable diabetes treatments The brand is the latest to plan dramatic price cuts for the diabetes drug
Radio France Internationale · Mar 14, 2023 Rwanda welcomes Africa's first mobile vaccine-production units Six mobile vaccine-production units developed by German pharmaceutical company BioNTech have arrived in Rwanda. This is the first such shipment to Africa as the continent seeks to boost local production of mRNA vaccines.
Tribune News Service · Mar 13, 2023 The VA will pay for some to get new Alzheimer’s drug The U.S. Veterans Health Administration will pay for some beneficiaries to get a new Alzheimer’s disease drug from Eisai Co. and Biogen Inc., positive news for a treatment that Eisai expects to bring in billions of dollar in sales in the next few years.
Tribune News Service · Mar 13, 2023 Pfizer to pay $43 billion for Seagen, set post-COVID course Pfizer Inc. is purchasing cancer-drug maker Seagen Inc. for an enterprise value of $43 billion, using the biggest deal of the year to set its course out of the pandemic and back into mainstream pharma.
StockNews.com · Mar 13, 2023 This Big Pharma Stock Is a Clear Buy in 2023 With interest rates expected to be higher than originally anticipated and fears of a looming recession weighing heavily on investors’ decisions, the stock market is expected to remain under pressure this year. Amid this backdrop, it could be wise for investors to invest in Johnson & Johnson (JNJ) due to…
StockNews.com · Mar 13, 2023 2 Top Biotech Stocks to Buy in March The biotech industry is expected to witness solid growth amid impressive advancements and government initiatives. Moreover, the biotech sector tends to be more defensive than others during market downturns. So, fundamentally sound biotech stocks Amgen (AMGN) and Biogen (BIIB) might be ideal buys now. Keep reading.
Tribune News Service · Mar 13, 2023 Pfizer to buy cancer drugmaker Seagen in $43 billion deal Pfizer Inc. agreed to purchase cancer-drug maker Seagen Inc. for an enterprise value of $43 billion, gaining the company’s antibody drugs that fight tumors.
Ballotpedia · Mar 13, 2023 Democratic attorneys general sue Biden administration over FDA abortion pill regulation A group of 12 Democratic state attorneys general filed a lawsuit in the United States District Court for the Eastern District of Washington against the Food and Drug Administration (FDA) on Feb. 23, 2023, arguing that the agency’s regulations on the abortion-inducing drug mifepristone violate state sovereignty by limiting the…
The Independent UK · Mar 13, 2023 Pfizer will spend $43 billion to acquire Seagen Pfizer will spend about $43 billion to buy Seagen and broaden its reach into cancer treatments, the pharmaceutical giant said Monday